Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1994-08-01
1996-07-30
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
435199, 530350, 514 12, A61K 3843, C12N 922
Patent
active
055409253
ABSTRACT:
A pharmaceutical to be sold under the ONCONASE trademark, as described in pending commonly owned application application Ser. No. 07/436,141 filed Nov. 13, 1989 is combined with other drugs sold under the trademarks TAMOXIFEN and STELAZINE. The combination of ONCONASE with TAMOXIFEN has unexpected bioactivity in vitro against ASPC-1 human pancreatic adenocarcinoma cells and the combination of ONCONASE with STELAZINE has unexpected bioactivity in vitro against A-549 human lung carcinoma cells.
REFERENCES:
patent: 4195017 (1980-03-01), Bogoch
patent: 4882421 (1989-11-01), Shogen et al.
patent: 4888172 (1989-12-01), Szebenyi et al.
Embase Abstract No.: 93284537. Phase I human clinical trial of ONCONASE (R) (P-30 protein) administered intravenously on a weekly schedule in cancer patients with solid tumors, Mikulski S. M.; Grossman A. M.; Carter P. W.; Shogen K.; Costanzi J. J., Int. J. ONCOL. (Greece), 1993, Mar. 1 (57-64).
McClay et al. 1988. Semin Oncol. 15(6):569-577 (Abstract Only), Dialog File 155 accession No. 8908 4596.
Hird et al. 1990. Genes and Cancer, John Wiley & Sons, Ltd., Corney et al. (eds). pp. 183-189, N.Y.
Mikulski et al. May 1990. Cell Tissue Kinet. 23:237-246.
Ardelt et al. 1991. J. Biol. Chem. 266(1):245-251.
Ardelt Wojciech J.
Mikulski Stanislaw M.
Alfacell Corporation
Carlson K. Cochrane
Wax Robert A.
LandOfFree
Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMO does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMO, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMO will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1656487